Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease Mariana Morais David Pliças; Bernardo Marques da Silva; Edgar Avito Fernandes de Almeida;

Enfermedad renal diabética y polimorfismos de los genes ELMO1 y AGTR1: revisión sistemática Yuliana Martínez-Nava; María Camila Ogaz-Escarpita; Sandra Alicia Reza-López; Irene Leal-Berumen;